Growing healthcare and health-related needs driven by Japan’s declining birthrate and aging population
First written in FY2016-Q4. 24 of 31 entries say "Restated". Latest entry: FY2025-H1.
No other company in this theme has enough history to compare yet.
- FY2025-H1RestatedAnnual report
「Research and development in the bioindustry is also expected to increase as a result of policies promoting the bioeconomy.」
The business environment was described as including demand for research and development related to health management and infectious disease prevention, as well as expected growth in bioindustry research and development against the backdrop of policies promoting the bioeconomy. - FY2024RestatedAnnual report
「The life sciences industry to which our group belongs is one of the few fields expected to grow despite the domestic environment of a declining birthrate and aging population. Interest in future infectious disease prevention and countermeasures is also high, investment in research and development has remained high, and this trend is expected to continue.」
The continued growth potential of the life sciences field and demand for research and development related to infectious disease prevention and countermeasures and health management are reconfirmed. - FY2024-Q3ReframedAnnual report
「Interest is also growing in the safety of foods with function claims and other products based on scientific evidence.」
In addition to the previous demand for research and development related to measures to address infectious diseases and health management, growing interest in the scientifically substantiated safety of foods with function claims has been added to the description of the business environment. - FY2024-Q2RestatedAnnual report
「In the life sciences industry to which our group belongs, the increasing trend in research and development driven by growing demand for health management continues, including the development of foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity, in addition to measures to address infectious diseases originating from the COVID-19 pandemic.」
The increasing trend in demand for research and development related to measures to address infectious diseases, foods with function claims, and health management continues to be described. - FY2024-Q1RestatedAnnual report
「In the life sciences industry to which our group belongs, the increasing trend in research and development driven by growing demand for health management continues, including the development of foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity, in addition to measures to address infectious diseases originating from the COVID-19 pandemic.」
The increasing trend in demand for research and development related to measures to address infectious diseases, foods with function claims, and health management continues to be described. - FY2023-Q3RestatedAnnual report
「In the life sciences industry to which our group belongs, the increasing trend in research and development driven by growing demand for health management continues, including the development of therapeutics and vaccines to address the COVID-19 pandemic and foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity.」
The increasing trend in demand for research and development related to therapeutics and vaccines, foods with function claims, and health management continues to be described. - FY2023-Q2RestatedAnnual report
「In the life sciences industry to which our group belongs, the increasing trend in research and development driven by growing demand for health management continues, including the development of therapeutics and vaccines to address the COVID-19 pandemic and foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity.」
The increasing trend in demand for research and development related to therapeutics and vaccines, foods with function claims, and health management continues to be described. - FY2023-Q1RestatedAnnual report
「In the life sciences industry to which our group belongs, the increasing trend in research and development driven by growing demand for health management continues, including the development of therapeutics and vaccines to address the COVID-19 pandemic and foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity.」
The increasing trend in demand for research and development related to therapeutics and vaccines, foods with function claims, and health management continues to be described. - FY2022-Q3RestatedAnnual report
「In the life sciences industry to which our group belongs, research and development is increasing in response to growing demand for health management, including the development of therapeutics and vaccines to address the COVID-19 pandemic and foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity.」
The increasing trend in demand for research and development related to therapeutics and vaccines, foods with function claims, and health management continues to be described. - FY2022-Q2RestatedAnnual report
「In the life sciences industry to which our group belongs, research and development is increasing in response to growing demand for health management, including the development of therapeutics and vaccines to address the COVID-19 pandemic and foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity. At the same time, delays in clinical trials and restrictions on access to research facilities due to COVID-19 have, in some cases, made it difficult to adequately meet demand for research and development.」
The increasing demand for research and development related to measures to address infectious diseases and health management, together with constraints on meeting that demand due to delays in clinical trials and restrictions on access to research facilities, continues to be described. - FY2022-Q1WorsenedAnnual report
「At the same time, delays in clinical trials caused by the fifth wave of COVID-19 and restrictions on access to research facilities have, in some cases, made it difficult to adequately meet demand for research and development.」
Although demand for research and development related to measures to address infectious diseases and health management is increasing, constraints on meeting that demand due to delays in clinical trials caused by the fifth wave and restrictions on access to research facilities continue. - FY2021RestatedAnnual report
「In the life sciences industry to which our company belongs, research and development is increasing in response to growing demand for health management, including the development of therapeutics and vaccines to address the COVID-19 pandemic and foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity.」
The increasing trend in demand for research and development related to measures to address infectious diseases, foods with function claims, and health management continues to be described. - FY2021-Q3WorsenedAnnual report
「At the same time, delays in clinical trials caused by the second and third waves of COVID-19 and restrictions on access to research facilities have, in some cases, made it difficult to adequately meet demand for research and development. In particular, most of the third quarter of the fiscal year under review coincided with a state of emergency, resulting in significant delays in research and development.」
Although demand for research and development is increasing, delays in research and development became significant due to the second and third waves, restrictions on access to facilities, and the state of emergency. - FY2021-Q2RestatedAnnual report
「In the life sciences industry to which our company belongs, research and development is increasing in response to growing demand for health management, including the development of therapeutics and vaccines to address the COVID-19 pandemic and foods with function claims designed to promote the prevention of infectious diseases, such as by improving immunity. At the same time, delays in clinical trials and restrictions on access to research facilities to prevent the spread of COVID-19 have, in some cases, made it difficult to adequately meet demand for research and development.」
The growing demand for research and development in areas including measures to address infectious diseases and the development of foods with function claims, together with constraints on meeting that demand due to delays in clinical trials and restrictions on access to research facilities, continues to be described. - FY2021-Q1ReframedAnnual report
「In the life sciences industry to which our group belongs, research and development is increasing in response to growing demand for health management, including the development of therapeutics and vaccines to address the COVID-19 pandemic and functional foods designed to promote the prevention of infectious diseases, such as by improving immunity. At the same time, delays in clinical trials and restrictions on access to research facilities to prevent the spread of COVID-19 have, in some cases, made it difficult to adequately meet the growing demand for research and development.」
In addition to the previous demand for preventive medicine and health management, the disclosure describes demand for research and development of therapeutics and vaccines and functional foods for preventing infectious diseases, as well as constraints on meeting that demand due to delays in clinical trials and restrictions on access to research facilities. - FY2020RestatedAnnual report
「The life sciences industry to which our company belongs is one of the few fields expected to grow despite the domestic environment of a declining birthrate and aging population. Interest in measures to address the COVID-19 pandemic is also high, investment in research and development has remained high, and this trend is expected to continue.」
The growth potential of the life sciences field, investment in research and development, and growing demand for health management and measures to address infectious diseases continue to be described as part of the business environment. - FY2020-Q3ReframedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care. Against the backdrop of growing interest in measures to address the COVID-19 pandemic, demand for research and development and for health management and related services is also growing worldwide.」
Growing global demand for preventive and personalized medicine and health management, together with interest in measures to address the COVID-19 pandemic, has been added to the description of the business environment. - FY2020-Q2RestatedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The promotion of preventive and personalized medicine and growing global demand for health management and related services continue to be described as part of the business environment. - FY2020-Q1RestatedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The promotion of preventive and personalized medicine and growing global demand for health management and related services continue to be described as part of the business environment. - FY2019RestatedAnnual report
「Moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The growing global demand for preventive and personalized medicine and health management is reconfirmed as part of the business environment. - FY2019-Q3RestatedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The promotion of preventive and personalized medicine and growing global demand for health management and related services continue to be described. - FY2019-Q2RestatedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The promotion of preventive and personalized medicine and growing global demand for health management and related services continue to be described. - FY2019-Q1RestatedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The promotion of preventive and personalized medicine and growing global demand for health management and related services continue to be described as part of the business environment. - FY2018-Q4RestatedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The promotion of preventive and personalized medicine and growing global demand for health management and related services continue to be described as part of the business environment. - FY2018-Q2RestatedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The promotion of preventive and personalized medicine and growing global demand for health management and related services continue to be described as part of the business environment. - FY2018-Q1RestatedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The promotion of preventive and personalized medicine and growing global demand for health management continue to be described as part of the business environment. - FY2017-Q4ReframedAnnual report
「In the life sciences industry to which our group belongs, moves to promote preventive and personalized medicine are increasing to improve the efficiency of medical care and nursing care, and demand for health management and related services is growing worldwide.」
The description of the business environment has changed from domestic demand for medical and healthcare products driven by the declining birthrate and aging population to growing global demand for preventive and personalized medicine and health management. - FY2017RestatedAnnual report
「Despite the domestic environment of a declining birthrate and aging population, this is one of the few fields expected to grow, and investment in research and development has remained high and is expected to continue at a similar level.」
The growth potential of the life sciences field and the continued investment in research and development driven by the declining birthrate and aging population are reiterated. - FY2017-Q2RestatedAnnual report
「In the life sciences industry to which our company belongs, demand is growing for pharmaceuticals, medical devices, healthcare products, and other products that contribute to improving healthcare cost-effectiveness and extending healthy life expectancy, against the backdrop of the declining birthrate and aging population, and research and development in these fields is active.」
The expansion of medical and healthcare demand and increased research and development activity driven by the declining birthrate and aging population are reiterated. - FY2017-Q1RestatedAnnual report
「In the life sciences industry to which our company belongs, demand is growing for pharmaceuticals, medical devices, healthcare products, and other products that contribute to improving healthcare cost-effectiveness and extending healthy life expectancy, against the backdrop of the declining birthrate and aging population, and research and development in these fields is active.」
The expansion of medical and healthcare demand and increased research and development activity driven by the declining birthrate and aging population are reiterated. - FY2016-Q4First statedAnnual report
「Against the backdrop of the declining birthrate and aging population, demand is growing for pharmaceuticals, medical devices, healthcare products, and other products that contribute to improving healthcare cost-effectiveness and extending healthy life expectancy, and research and development in these fields is active.」
The structural demand and research and development trends in the life sciences industry are described as part of the business environment.